Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
100%
Anticoagulant Agent
86%
Rivaroxaban
85%
Venous Thromboembolism
70%
Pharmacokinetics
58%
Antivitamin K
53%
Apixaban
44%
Dabigatran
41%
Enoxaparin
37%
Clinical Trial
34%
Edoxaban
31%
Bleeding
29%
Warfarin
26%
Vitamin D
26%
Low Molecular Weight Heparin
25%
Atrial Fibrillation
17%
Base
17%
Prospective Cohort Study
15%
Diseases
14%
Thrombin
14%
Cholecalciferol
14%
Multiple Myeloma
13%
Cohort Study
13%
Multiple Sclerosis
13%
Elimination
13%
D Dimer
13%
Acetylsalicylic Acid
13%
Antibiotic Therapy
13%
Hemodialysis
13%
Hair Loss
13%
Chronic Kidney Failure
13%
Pharmacology
13%
Myeloma
13%
Alopecia
13%
Anticoagulation Therapy
10%
Drug
9%
Obesity
9%
Heparin
8%
Prevalence
8%
Incidence
7%
Chronic Disease
6%
Replacement Therapy
5%
Creatinine
5%
Thrombosis
5%
Acetonitrile
5%
Medicine and Dentistry
Patient
78%
Therapeutic Procedure
54%
Woman
46%
Anticoagulation
39%
Rivaroxaban
39%
Venous Thromboembolism
37%
Experience
28%
Thromboprophylaxis
28%
Pregnancy
28%
Combination Therapy
28%
Low Molecular Weight Heparin
27%
Puerperium
26%
Apixaban
26%
Dentoalveolar Surgery
26%
Drug Therapy
21%
Inpatient
16%
Consultation
14%
Complementary and Alternative Medicine
14%
Antithrombotic
13%
Heparinization
13%
Tandem Mass Spectrometry
13%
Disease
13%
Child
13%
Primary Health Care
13%
Attitude
13%
Edoxaban
13%
Association
13%
Acetylsalicylic Acid
13%
Lactation
13%
Obstetric Procedure
13%
D-Dimer
13%
Direct Oral Anticoagulant
13%
Antibiotic Therapy
13%
Traditional Chinese Medicine
13%
Program Effectiveness
13%
Pooled Analysis
13%
Vitamin D
13%
Plasma
13%
Myeloma
13%
Base
13%
Human Milk
13%
Randomized Controlled Trial
13%
Thrombin
13%
Cohort Analysis
13%
Multiple Myeloma
13%
Quality of Life
13%
Anticoagulant Therapy
7%
Bleeding
7%
Vitamin K Antagonist
7%
Chronic Disease
6%
Nursing and Health Professions
Patient
90%
Anticoagulant Agent
71%
Anticoagulation
49%
Woman
39%
Venous Thromboembolism
38%
Combination Therapy
29%
Drug Therapy
26%
Rivaroxaban
26%
Quality of Life
26%
Bleeding
24%
Control
18%
Drug
18%
Dose
17%
Prevalence
17%
Warfarin
17%
Anticoagulant Therapy
16%
Antivitamin K
16%
Adult
15%
Obesity
15%
Outpatient
14%
Low Molecular Weight Heparin
13%
Dabigatran
13%
Systematic Review
13%
Vitamin D
13%
Consultation
13%
Primary Medical Care
13%
Pharmacy
13%
Diseases
13%
Cohort Analysis
13%
Lived Experience
13%
Antibiotic Therapy
13%
International Normalized Ratio
13%
Clinical Effectiveness
13%
Hemodialysis
13%
Base
10%
Clinician
10%
World Health Organization
7%
Physician
7%
Time
6%
Therapy Effect
6%
Chronic Disease
6%
Analysis
6%
Continuous Renal Replacement Therapy
5%
Atrial Fibrillation
5%
Supplementation
5%
Weight
5%
Clearance
5%
Electric Potential
5%
Confidence Interval
5%
Error
5%
